Skip to main content Accessibility help
×
Home

Differential protein analysis of serum exosomes post-intravenous immunoglobulin therapy in patients with Kawasaki disease

  • Li Zhang (a1), Qi-Fang Song (a2), Jing-Jie Jin (a3), Ping Huang (a1), Zhou-Ping Wang (a1), Xiao-Fei Xie (a1), Xiao-Qiong Gu (a1), Xue-Juan Gao (a3) and Hong-Ling Jia (a3)...

Abstract

Background

Kawasaki disease, which is characterised by systemic vasculitides accompanied by acute fever, is regularly treated by intravenous immunoglobulin to avoid lesion formation in the coronary artery; however, the mechanism of intravenous immunoglobulin therapy is unclear. Hence, we aimed to analyse the global expression profile of serum exosomal proteins before and after administering intravenous immunoglobulin.

Methods

Two-dimensional electrophoresis coupled with mass spectrometry analysis was used to identify the differentially expressed proteome of serum exosomes in patients with Kawasaki disease before and after intravenous immunoglobulin therapy.

Results

Our analysis revealed 69 differential protein spots in the Kawasaki disease group with changes larger than 1.5-fold and 59 differential ones in patients after intravenous immunoglobulin therapy compared with the control group. Gene ontology analysis revealed that the acute-phase response disappeared, the functions of the complement system and innate immune response were enhanced, and the antibacterial humoral response pathway of corticosteroids and cardioprotection emerged after administration of intravenous immunoglobulin. Further, we showed that complement C3 and apolipoprotein A-IV levels increased before and decreased after intravenous immunoglobulin therapy and that the insulin-like growth factor-binding protein complex acid labile subunit displayed reverse alteration before and after intravenous immunoglobulin therapy. These observations might be potential indicators of intravenous immunoglobulin function.

Conclusions

Our results show the differential proteomic profile of serum exosomes of patients with Kawasaki disease before and after intravenous immunoglobulin therapy, such as complement C3, apolipoprotein A-IV, and insulin-like growth factor-binding protein complex acid labile subunit. These results may be useful in the identification of markers for monitoring intravenous immunoglobulin therapy in patients with Kawasaki disease.

Copyright

Corresponding author

#Correspondence to: X.-J. Gao and H.-L. Jia, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, 601 Huangpu Ave W, The 2nd Science and Technology Building, Room 914, Guangzhou 510632, China. Tel: +86 208 522 1071; Fax: +86 208 522 1071; E-mail: tgaoxj@jnu.edu.cn; jiahongling@aliyun.com

Footnotes

Hide All
*

Li Zhang, Qi-Fang Song, and Jing-Jie Jin contributed equally to this work.

Footnotes

References

Hide All
1. Burns, JC, Glodé, MP. Kawasaki syndrome. Lancet 2004; 364: 533544.
2. Kawasaki, T, Kosaki, F, Okawa, S, Shigematsu, I, Yanagawa, H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 271276.
3. Lin, MT, Sun, LC, Wu, ET, Wang, JK, Lue, HC, Wu, MH. Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy. Arch Dis Child 2015; 100: 542547.
4. Makino, N, Nakamura, Y, Yashiro, M, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol 2015; 25: 239245.
5. Heuclin, T, Dubos, F, Hue, V, et al. Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography. J Pediatr 2009; 155: 695699.
6. Ho, CL, Fu, YC, Lin, MC, Jan, SL. Early immunoglobulin therapy and outcomes in Kawasaki disease: a nationwide cohort study. Medicine (Baltimore) 2015; 94: e1544.
7. Patel, RM, Shulman, ST. Kawasaki disease: a comprehensive review of treatment options. J Clin Pharm Ther 2015; 40: 620625.
8. Ballow, M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 2011; 127: 315323.
9. Zhou, C, Huang, M, Xie, L, Shen, J, Xiao, T, Wang, R. IVIG inhibits TNF-α-induced MMP9 expression and activity in monocytes by suppressing NF-κB and P38 MAPK activation. Int J Clin Exp Pathol 2015; 8: 1587915886.
10. Pap, E, Pállinger, E, Pásztói, M, Falus, A. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 2009; 58: 18.
11. Lakkaraju, A, Rodriguez-Boulan, E. Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol 2008; 18: 199209.
12. Mathivanan, S, Ji, H, Simpson, RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010; 73: 19071920.
13. Yoon, YJ, Kim, OY, Gho, YS. Extracellular vesicles as emerging intercellular communicasomes. BMB Rep 2014; 47: 531539.
14. Inal, JM, Kosgodage, U, Azam, S, Stratton, D, Antwi-Baffour, S, Lange, S. Blood/plasma secretome and microvesicles. Biochim Biophys Acta 2013; 1834: 23172325.
15. Kosaka, N, Iguchi, H, Yoshioka, Y, Takeshita, F, Matsuki, Y, Ochiya, T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285: 1744217452.
16. Hwang, I, Ki, D. Receptor-mediated T cell absorption of antigen presenting cell-derived molecules. Front Biosci 2011; 16: 411421.
17. Zhou, DH, Yuan, ZG, Zhao, FR, et al. Modulation of mouse macrophage proteome induced by Toxoplasma gondii tachyzoites in vivo. Parasitol Res 2011; 109: 16371646.
18. Wu, G, Dawson, E, Duong, A, Haw, R, Stein, L. ReactomeFIViz: a Cytoscape app for pathway and network-based data analysis. Version 2 F1000Res 2014; 3: 146.
19. Yu, HR, Kuo, HC, Sheen, JM, et al. A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease. Pediatr Allergy Immunol 2009; 20: 699707.
20. Boguski, MS, Elshourbagy, N, Taylor, JM, Gordon, JI. Rat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid segment with amphipathic helical potential. Proc Natl Acad Sci U S A 1984; 81: 50215025.
21. Kalogeris, TJ, Rodriguez, MD, Tso, P. Control of synthesis and secretion of intestinal apolipoprotein A-IV by lipid. J Nutr 1997; 127: 537S543S.
22. Weinberg, RB, Cook, VR, DeLozier, JA, Shelness, GS. Dynamic interfacial properties of human apolipoproteins A-IV and B-17 at the air/water and oil/water interface. J Lipid Res 2000; 41: 14191427.
23. Canales, A, Benedi, J, Bastida, S, et al. The effect of consuming meat enriched in walnut paste on platelet aggregation and thrombogenesis varies in volunteers with different apolipoprotein A4 genotype. Nutr Hosp 2010; 25: 746754.
24. Wong, WM, Hawe, E, Li, LK, et al. Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ Res 2003; 92: 969975.
25. Fofanova-Gambetti, OV, Hwa, V, Kirsch, S, et al. Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins. Horm Res 2009; 71: 100110.
26. Domené, HM, Scaglia, PA, Martínez, AS, et al. Heterozygous IGFALS gene variants in idiopathic short stature and normal children: impact on height and the IGF system. Horm Res Paediatr 2013; 80: 413423.

Keywords

Type Description Title
WORD
Supplementary materials

Zhang supplementary material
Table S1

 Word (125 KB)
125 KB
WORD
Supplementary materials

Zhang supplementary material
Table S2

 Word (111 KB)
111 KB

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed